LIVOSTIN gtt opht 0.5 mg/ml fl 4 ml

7680504960234 CH-50496 S01GX02 11.06.2.

Active substances:

LIVOSTIN gtt opht 0.5 mg/ml fl 4 ml
LIVOSTIN gtt opht 0.5 mg/ml fl 4 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5049601
CPT
-
Packaging group
4
Unit
ml
Composition
levocabastinum 0.5 mg ut levocabastini hydrochloridum, propylenglycolum, dinatrii phosphas et natrii dihydrogenophosphas monohydricus corresp. phosphas 9.5 mg, benzalkonii chloridum 0.15 mg, hypromellosum, polysorbatum 80, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Livostin Augentropfen, Augentropfensuspension
Augentropfensuspension
4
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/04/2025
Patient information leaflet
Français
28/04/2025
Patient information leaflet
Italien
28/04/2025
Professional SmPC
Allemand
28/04/2025
Professional SmPC
Français
28/04/2025
Professional SmPC
Italien
28/04/2025

Detailed composition

Substance Quantity Type Category
levocabastinum
0.5 MG Substance Wirkstoff (Principe actif)
levocabastini hydrochloridum
- Substance WIZUS
propylenglycolum
- Substance HNIDK
dinatrii phosphas
- Substance HNIDK
natrii dihydrogenophosphas monohydricus
- Substance HNIDK
phosphas
9.5 MG Substance HBESI
benzalkonii chloridum
0.15 MG Substance HBESI
hypromellosum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 12.50
Specialties list
Yes
Generic
No
SL addition date: 15/03/1992

Authorization holder

JNTL Consumer Health II

6343 Risch

Authorization information

Swissmedic authorization number
50496
Drug name
Livostin Augentropfen, Augentropfensuspension
Galenic form
AUGN
ATC Code
S01GX02
Authorization status
Z
Dispensation category
D
First authorization
28/02/1992
Authorization expiration date
31/12/9999
IT number
11.06.2.
Domain
Human medicine
Field of application
Allergische Konjunktivitis

Packaging details

Description (FR)
LIVOSTIN gtt opht 0.5 mg/ml fl 4 ml
Description (DE)
LIVOSTIN Gtt Opht 0.5 mg/ml Fl 4 ml
Market launch
28/02/1992
Narcotic (BTM)
No
Buy us a coffee Explore the data